Methods and compositions for treating and preventing respiratory related diseases and conditions with xylitol-headgroup lipid analogs
AssigneeNational Jewish Health
InventorDennis R. Voelker
Life of this patent
Estimating the term…
Abstract
The invention generally relates to methods to prevent and/or inhibit viral infection as well as to inhibit inflammation and/or pathogen infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual. The invention also relates to methods to prevent or inhibit respiratory syncytial virus (RSV) infection by administering at least one xylitol lipid analog or compositions comprising at least one xylitol lipid analog to an individual.
Claims11
A method to inhibit respiratory syncytial virus (RSV) infection in an individual who has, or is at risk of developing RSV infection, the method comprising administering to the individual at least one xylitol lipid analog, wherein the amount of the xylitol lipid analog is effective to inhibit said viral infection, and wherein the xylitol lipid analog is selected from the group consisting of Dipalmitoleoyl-phosphatidylxylitol (16:1 DPPX), Dioleoyl-phosphatidylxylitol (DOPX), Palmitoyl-oleoyl-phosphatidylxylitol (POPX), and Dilinoleoyl-phosphatidylxylitol (18:2 DLPX).
Dependencies are inferred from the claim text.